Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-10

Clinical Trial Update: Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease [NA]

View source ↗

Summary

A completed clinical trial compared Capso Vision SV-1 to PillCam SB2 for evaluation of suspected small bowel disease, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capso Vision SV-1
  • PillCam SB2

Snippet

Sponsor: Capso Vision, Inc. | Conditions: Intestinal Disease, Inflammatory Bowel Disease | NA | Status: COMPLETED | Results posted: 2017-05-10